Harvard Bioscience Inc (HBIO)
3.85
+0.03
(+0.79%)
USD |
NASDAQ |
May 03, 16:00
3.89
+0.04
(+1.04%)
Pre-Market: 20:00
Harvard Bioscience Net Income (Quarterly): -1.818M for Dec. 31, 2023
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -1.818M |
| September 30, 2023 | -1.239M |
| June 30, 2023 | -0.98M |
| March 31, 2023 | 0.622M |
| December 31, 2022 | -1.666M |
| September 30, 2022 | -3.405M |
| June 30, 2022 | 2.435M |
| March 31, 2022 | -6.88M |
| December 31, 2021 | 0.961M |
| September 30, 2021 | -0.17M |
| June 30, 2021 | -0.41M |
| March 31, 2021 | -0.669M |
| December 31, 2020 | -0.615M |
| September 30, 2020 | -1.098M |
| June 30, 2020 | -1.581M |
| March 31, 2020 | -4.516M |
| December 31, 2019 | 0.55M |
| September 30, 2019 | -2.62M |
| June 30, 2019 | -0.247M |
| March 31, 2019 | -2.37M |
| December 31, 2018 | 2.862M |
| September 30, 2018 | -0.256M |
| June 30, 2018 | -1.464M |
| March 31, 2018 | -4.064M |
| December 31, 2017 | 0.999M |
| Date | Value |
|---|---|
| September 30, 2017 | -0.417M |
| June 30, 2017 | -0.381M |
| March 31, 2017 | -1.066M |
| December 31, 2016 | -1.32M |
| September 30, 2016 | -1.638M |
| June 30, 2016 | -0.713M |
| March 31, 2016 | -0.636M |
| December 31, 2015 | -17.14M |
| September 30, 2015 | -0.847M |
| June 30, 2015 | 0.349M |
| March 31, 2015 | -1.401M |
| December 31, 2014 | -0.019M |
| September 30, 2014 | 0.633M |
| June 30, 2014 | 1.022M |
| March 31, 2014 | 0.719M |
| December 31, 2013 | -0.756M |
| September 30, 2013 | -0.983M |
| June 30, 2013 | -0.186M |
| March 31, 2013 | 0.096M |
| December 31, 2012 | 1.202M |
| September 30, 2012 | -0.133M |
| June 30, 2012 | 0.774M |
| March 31, 2012 | 0.529M |
| December 31, 2011 | 0.738M |
| September 30, 2011 | 0.028M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-6.88M
Minimum
Mar 2022
2.435M
Maximum
Jun 2022
-1.229M
Average
-0.98M
Median
Jun 2023
Net Income (Quarterly) Benchmarks
| Bruker Corp | 50.90M |
| Azenta Inc | -15.72M |
| Bionano Genomics Inc | -43.89M |
| Akoya Biosciences Inc | -10.80M |
| Singular Genomics Systems Inc | -23.25M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 28.15M |
| Total Expenses (Quarterly) | 27.87M |
| EPS Diluted (Quarterly) | -0.04 |
| Enterprise Value | 199.37M |
| Gross Profit Margin (Quarterly) | 57.99% |
| Profit Margin (Quarterly) | -6.46% |
| Earnings Yield | -2.08% |
| Operating Earnings Yield | 1.15% |
| Normalized Earnings Yield | -1.768 |